Breakthrough in Migraine Care

PROVIDING SAFER AND MORE EFFECTIVE
MIGRAINE MEDICATION

OUR PHILOSOPHY

Seurat aims to stop migraines before they start.

Studies have shown that Environmental Enrichment, a naturally-induced biological phenomenon, can reduce brain diseases by half.

By replicating Environmental Enrichment through a therapeutic approach, we can not only stop migraines in their tracks but also prevent them in the future.

 
OUR STORY

Seurat Therapeutics sprung from the University of Chicago and is currently based at the Polsky Exchange. We are a team passionate about innovating migraine care and accelerating the translation of scientific discoveries into life-changing medicine. 

OUR VISION

In the U.S., 1 out of 10 people suffer from migraines. Due to the lack of medicine that truly treat the cause of these migraines, patients are often left helpless and have to resort to bed rest for hours to days. Our mission is to give these people their lives back.

OUR APPROACH

The science behind Seurat Therapeutics is based on years of research from the University of Chicago medical center. Our treatment philosophy stems from a belief that novel neurotherapeutics based on EE can improve brain health.

OUR TEAM

MARTIN SANDERS, MD

Co-Founder

Chairman

YUAN ZHANG, PHD, MS

Co-Founder

CEO and President

RICHARD KRAIG, MD, PHD

Co-Founder

Chief Scientific Officer

SHARON LEW, MS

Chief Financial Officer

Scott Meadow, MBA

Board Member

 
 

Contact

Us

(312) 248-2964
Polsky Exchange
1452 East 53rd Street, 2nd Floor
Chicago, IL 60615

Copyright © 2017 Seurat Therapeutics Inc. All rights reserved.